OrganOx Ltd, a world-leading organ medical technology company, today announced Health Canada has approved the OrganOx metra ® System for use during liver transplantation. The OrganOx metra ® System is ...

Conformal Medical, Inc. today announced the initiation of the GLACE Study. This European study* aims to assess the use of intracardiac echocardiography (ICE) imaging of the left atrial appendage (LAA) ...

When it comes to personal health, many issues command immediate attention. A cough, fever, or injury are clear signs that something might be wrong. However, some conditions, like nail fungus, often go ...

The biopharma industry is at the forefront of medical innovation, driven by the groundbreaking work of leading scientists. These individuals are not only advancing our understanding of complex ...

Philips helps healthcare organizations worldwide assess and mitigate their environmental impact while enabling better care and better care outcomes for more patients at lower cost “Good healthcare has ...

"The use of ICE imaging in LAAO is growing significantly and will continue," said James Reinstein, President and CEO of Conformal Medical. "Our next-generation LAAO technology conforms to individual ...

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and ...

Celaid Therapeutics Inc. announced today that it has been awarded up to approx. 2.7 billion yen ($19M USD) in non-dilutive grant funding as “Strengthening Program for Pharmaceutical Startup Ecosystem” ...

Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, has installed the first non-invasive prenatal testing ...

Syncona Ltd, (“Syncona” or the “Company”), a leading life science investor focused on creating, building and scaling a portfolio of global leaders in life science, today announces that it has ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series ...

The developments will be tested at Hospital General Universitario de Valencia, which participates in the NOSOSENS project through its research foundation, together with AIMPLAS, Química ...